Mount Sinai Institute for Systems Biomedicine

Search results

• RenalytixAI Initiates Clinical Validation Study Of AI-Enabled KidneyIntelX™ For Diagnosing Fast-Progressing Kidney Disease

  Girish Nadkarni, Barbara Murphy & Steven Coca

  25/01/19

  1 item of Media coverage

  Press/Media

• RenalytixAI Initiates Clinical Validation Study of AI-Enabled KidneyIntelX™ for Diagnosing Fast ...

  Girish Nadkarni, Barbara Murphy & Steven Coca

  24/01/19

  1 item of Media coverage

  Press/Media

• RenalytixAI Initiates Clinical Validation Study of AI-Enabled KidneyIntelXâ„¢ for Diagnosing Fast-Progressing Kidney Disease

  Girish Nadkarni, Barbara Murphy & Steven Coca

  24/01/19

  1 item of Media coverage

  Press/Media

• RenalytixAI Initiates Clinical Validation Study of AI-Enabled KidneyIntelX™ for Diagnosing Fast-Progressing Kidney Disease

  Girish Nadkarni, Barbara Murphy & Steven Coca

  23/01/19 → 24/01/19

  5 items of Media coverage

  Press/Media

• Renalytix AI PLC - RENX Initiates Clinical Validation Study (Updated 23 Jan 2019)

  Girish Nadkarni, Barbara Murphy & Steven Coca

  24/01/19

  1 item of Media coverage

  Press/Media

• RenalytixAI Initiates Clinical Validation Study of AI-Enabled KidneyIntelX(TM) for Diagnosing Fast-Progressing Kidney Disease; Validation study to assess approximately 5,000 patients with participation from a multi-center group of leading U.S. investigato

  Girish Nadkarni, Barbara Murphy & Steven Coca

  23/01/19

  1 item of Media coverage

  Press/Media

• RenalytixAI Initiates Clinical Validation Study of AI-Enabled KidneyIntelX for Diagnosing Fast-Progressing Kidney Disease

  Girish Nadkarni, Barbara Murphy & Steven Coca

  23/01/19

  1 item of Media coverage

  Press/Media

• Renalytix AI PLC Initiates Clinical Validation Study

  Girish Nadkarni, Barbara Murphy & Steven Coca

  23/01/19

  1 item of Media coverage

  Press/Media

• Initiates Clinical Validation Study

  Girish Nadkarni, Barbara Murphy & Steven Coca

  23/01/19

  1 item of Media coverage

  Press/Media

• RENALYTIXAI : Initiates Clinical Validation Study of AI-Enabled KidneyIntelX™ for Diagnosing Fast-Progressing Kidney Disease

  Girish Nadkarni, Barbara Murphy & Steven Coca

  23/01/19

  1 item of Media coverage

  Press/Media

• Renalytix AI PLC : Initiates Clinical Validation Study

  Girish Nadkarni, Barbara Murphy & Steven Coca

  23/01/19

  1 item of Media coverage

  Press/Media

• RenalytixAI raises $29 million to commercialize AI-enabled clinical diagnostic solutions for kidney disease

  Barbara Murphy

  16/11/18

  1 item of Media coverage

  Press/Media

• RenalytixAI Raises $29 Million to Commercialize AI-Enabled Clinical Diagnostic Solutions for Kidney Disease

  Barbara Murphy

  15/11/18 → 16/11/18

  10 items of Media coverage

  Press/Media

• RenalytixAI scores $29M for AI-based kidney disease diagnostics

  Barbara Murphy

  15/11/18

  2 items of Media coverage

  Press/Media

• RenalytixAI Raises $29 Million

  Barbara Murphy

  15/11/18

  1 item of Media coverage

  Press/Media

• Mount Sinai Technology Spinout RenalytixAI Completes Initial Public Offering, Raising $29 Million ...

  Barbara Murphy

  15/11/18

  1 item of Media coverage

  Press/Media

• RenalytixAI Raises $29 Million to Commercialize AI-Enabled Clinical Diagnostic Solutions for Kidney Disease; Solutions to Improve Detection, Management and Treatment of Kidney Disease, Which Impacts More Than 850 Million Globally

  Barbara Murphy

  15/11/18

  1 item of Media coverage

  Press/Media

• RENALYTIXAI : Raises $29 Million to Commercialize AI-Enabled Clinical Diagnostic Solutions for Kidney Disease

  Barbara Murphy

  15/11/18

  1 item of Media coverage

  Press/Media

• Mount Sinai AI kidney disease startup raises $29M in IPO

  Barbara Murphy

  14/11/18

  1 item of Media coverage

  Press/Media

• Mount Sinai technology spinout RenalytixAI completes IPO raising $29 million to combat kidney disease

  Barbara Murphy

  13/11/18

  1 item of Media coverage

  Press/Media

• Mount Sinai Health System: Mount Sinai Technology Spinout RenalytixAI Completes Initial Public Offering, Raising $29 Million to Combat Kidney Disease

  Barbara Murphy

  13/11/18

  1 item of Media coverage

  Press/Media

• Mount Sinai Technology Spinout RenalytixAI Completes Initial Public...

  Barbara Murphy

  13/11/18

  4 items of Media coverage

  Press/Media

• Good news story! New Irish world changers in science and healthcare

  Barbara Murphy

  8/11/18 → 9/11/18

  2 items of Media coverage

  Press/Media

• The New Irish World Changers

  Barbara Murphy

  7/11/18

  1 item of Media coverage

  Press/Media

• Matthew A. Weissman, MD, MBA, Appointed Chair of Medicine at Mount Sinai Beth Israel

  Barbara Murphy

  29/10/18 → 30/10/18

  12 items of Media coverage

  Press/Media